On December 2, 2020, BetterLife Pharma Inc., an emerging biotech company, closed its brokered private placement offering of special warrants, pursuant to which the company issued 5,889,735 special warrants at a price of $0.50 per special warrant, for aggregate gross proceeds of C$2,944,867.50. The offering was led by Mackie Research Capital Corporation, as lead agent and sole bookrunner, on behalf of a syndicate of agents that included Haywood Securities Inc.
Fasken advised Mackie Research Capital Corporation with a team led by John Sabetti, and including Jordana Keslassy, Onyi Ubah and Julie He.
Fasken advised Mackie Research Capital Corporation with a team led by John Sabetti, and including Jordana Keslassy, Onyi Ubah and Julie He.
Jurisdiction
- British Columbia
